Sesen Bio is a late-stage company developing fusion protein medicines for the treatment of patients with cancer.

Biotechnology

Sesen Bio

Sesen Bio's headquarters in Cambridge, MA, United States

Thomas Cannell

Chad A. Myskiw

Sachin Pannuri

Omar Rifi

Mark R. Sullivan

Erin Clark

Glen C. Macdonald

Monica Forbes

Jay S. Duker

Carrie L. Bourdow

Jane V. Henderson

Peter K Honig

Michael A.s. Jewett

Jason Keyes

Rian Dickstein

Thomas Keane

Michael O’donnell

Alon Weizer

Fred N. Wolk

Wendy L. Dixon

Howard L. Levine

Daniel S. Lynch

Donald Lamm

Neal D. Shore

Dana Dunn

Louise Park Stejbach

Wassim Kassouf

The Scientific Advisory Team at Sesen Bio provides expert guidance and strategic advice on the development and clinical application of fusion protein medicines. Comprised of highly experienced members, this team ensures the scientific integrity and efficacy of the company's cancer treatment innovations.

Scientific Advisory Team

The Leadership Team at Sesen Bio guides the strategic direction and operational efficiency of the company as it develops innovative fusion protein medicines for cancer treatment. This team, composed of executives across key functional areas such as supply chain, manufacturing, corporate strategy, finance, and technical operations, works collaboratively to align resources, drive business growth, manage investor relations, and ensure the successful delivery of therapeutics to market. Their collective expertise fosters a culture of innovation and accountability essential for advancing Sesen Bio's mission.

Leadership Team

Sesen Bio

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Sesen Bio

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Related companies